Favorable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning allogeneic bone marrow stem cell transplantation.

被引：0
|
作者：
Malladi, RK
Peniket, AJ
Norton, AE
Samol, J
Campbell, AJ
Jones, J
Keen-McGuire, A
Littlewood, TJ
机构：
[1] John Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England
[2] Churchill Hosp, Cytogenet Lab, Oxford OX3 7LJ, England
来源：
BLOOD | 2003年 / 102卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5602
引用
收藏
页码：469B / 469B
页数：1
相关论文
共 50 条
  • [1] Fludarabine-melphalan reduced-intensity conditioning matched sibling bone marrow stem cell transplantation is an effective treatment for myeloid disorders
    Malladi, R
    Peniket, A
    Collins, G
    Littlewood, T
    BONE MARROW TRANSPLANTATION, 2004, 33 : S116 - S116
  • [2] Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodies
    Malladi, RK
    Peniket, AJ
    Norton, AE
    Campbell, AJ
    Collins, GP
    Samol, J
    Eagleton, H
    Miller, E
    Morgenstern, G
    Jones, J
    Keen-Mcguire, A
    Barnardo, M
    Littlewood, TJ
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2004, 73 (02) : 85 - 92
  • [3] Melphalan Dose in Patients with Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation with Reduced-Intensity Fludarabine and Melphalan
    Harada, Kaito
    Machida, Shinichiro
    Yanada, Masamitsu
    Kanamori, Heiwa
    Onizuka, Makoto
    Ozawa, Yukiyasu
    Kobayashi, Hikaru
    Sawa, Masashi
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Yano, Shingo
    BLOOD, 2017, 130
  • [4] Reduced-intensity allogeneic hematopoietic cell transplantation using fludarabine-melphalan conditioning for treatment of mature T-cell lymphomas
    Delioukina, M.
    Zain, J.
    Palmer, J. M.
    Tsai, N.
    Thomas, S.
    Forman, S.
    BONE MARROW TRANSPLANTATION, 2012, 47 (01) : 65 - 72
  • [5] Gemcitabine, Fludarabine; and Melphalan for Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Anderlini, Paolo
    Saliba, Rima M.
    Ledesma, Celina
    Plair, Tamera
    Alousi, Amin M.
    Hosing, Chitra M.
    Khouri, Issa F.
    Nieto, Yago
    Popat, Uday R.
    Shpall, Elizabeth J.
    Fanale, Michelle A.
    Hagemeister, Frederick B.
    Oki, Yasuhiro
    Neelapu, Saatva
    Romaguera, Jorge E.
    Younes, Anas
    Champlin, Richard E.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (07) : 1333 - 1337
  • [6] Fludarabine-melphalan as reduced-intensity conditioning for allogeneic stem cell transplantation in AML beyond complete remission: 10-year single centre experience
    Karas, M.
    Steinerova, K.
    Svoboda, T.
    Lysak, D.
    Vokurka, S.
    Vozobulova, V.
    Jindra, P.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S400 - S401
  • [7] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Arana, MG
    Riccardi, M
    Locasciulli, A
    Bacigalupo, A
    Di Bartolomeo, P
    Scimè, R
    Olivieri, A
    Narni, F
    De Fabritiis, P
    Corradini, P
    BONE MARROW TRANSPLANTATION, 2004, 33 : S37 - S38
  • [8] Reduced-intensity conditioning with treosulfan and fludarabine for allogeneic hematopoietic stem cell transplantation
    Nihtinen, A
    Volin, L
    Juvonen, E
    Ruutu, T
    BONE MARROW TRANSPLANTATION, 2003, 31 : S159 - S159
  • [9] Reduced-intensity conditioning with thiotepa, fludarabine and melphalan for allogeneic transplantation in multiple myeloma
    Majolino, I
    Carnevalli, E
    Locasciulli, A
    Di Bartolomeo, P
    Scimè, R
    Corradini, P
    Selleri, M
    Narni, F
    Musso, M
    Bregni, M
    Olivieri, A
    De Fabritiis, P
    Pogliani, L
    Ruscio, C
    Bacigalupo, A
    BONE MARROW TRANSPLANTATION, 2006, 37 : S144 - S145
  • [10] Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma
    Kekre, Natasha
    Marquez-Malaver, Francisco J.
    Cabrero, Monica
    Pinana, Jl
    Esquirol, Albert
    Soiffer, Robert J.
    Caballero, Dolores
    Terol, M. J.
    Martino, Rodrigo
    Antin, Joseph H.
    Lopez-Corral, L.
    Solano, Carlos
    Armand, Philippe
    Perez-Simon, Jose A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2016, 22 (10) : 1808 - 1815
12345